Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-24 @ 2:07 PM
NCT ID:
NCT03012295
Eligibility Criteria:
Inclusion Criteria:
* hypertension patients meet one of the following criteria
1. Beginning age of hypertension: \<35 years (regardless of family history of hypertension);
2. refractory hypertension (blood pressure is difficult to control): triple antihypertensive drugs treatment for 1 months, 3 times of non-continuous high blood pressure in consulting room (SBP ≥140mmHg and/or DBP≥90mmHg);
* patients suspected of secondary hypertension, meeting one of the following criteria
1. pheochromocytoma or Cushing syndrome;
2. hypertension with hypokalemia;
3. hypertension with hyperkalemia;
4. hypertension with special body shape, such as central obesity, moon face, acne etc..
5. adrenal tumor;
Exclusion Criteria:
* renal parenchymal / renovascular hypertension
* patients exceed age of 50, and with coronary heart disease and arteriosclerosis
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
50 Years
Study:
NCT03012295
Study Brief:
Protocol Section:
NCT03012295